Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 3,808,443Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Accord Healthcare Ag

02 4Accord Healthcare S.L.U.

03 6Accord Healthcare Slu

04 2Amgen Europe B.V.

05 1Amgen Europe B.V. (2)

06 4Amgen Europe Bv

07 2Amgen Switzerland Ag

08 2Aryogen Pharmed

09 2Biocon Biologics Limited

10 8Biosimilar Collaborations Ireland Limited

11 2Celltrion Healthcare Hungary Kft

12 5Celltrion Healthcare Hungary Kft.

13 2Celltrion Healthcare Hungary Kft. (1)

14 2Curateq Biologics S.R.O.

15 1Daiichi Sankyo Europe GmbH

16 4Daiichi Sankyo Europe Gmbh

17 6F. Hoffmann-La Roche, Ltd.

18 2Iqone Healthcare Switzerland Sa

19 2Medius Ag

20 2Pfizer Ag

21 2Pfizer Europe MA EEIG (1)

22 6Pfizer Europe Ma Eeig

23 2Prestige Biopharma Belgium

24 2Prestige Biopharma Bvba

25 2ROCHE REGISTRATION LTD

26 7Roche Pharma (Switzerland) Ag

27 4Roche Registration GmbH

28 18Roche Registration Gmbh

29 1Roche Registration Ltd

30 4Samsung Bioepis Nl B.V.

31 2Samsung Bioepis Nl Bv

32 2Sandoz Gmbh

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Trastuzumab

Brand Name : Dazublys

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 150mg

Packaging :

Approval Date : 10/07/2025

Application Number : 20240115000111

Regulatory Info : Approved

Registration Country : Sweden

blank

02

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Trastuzumab

Brand Name : Herceptin

Dosage Form : Trastuzumab 150Mg 1 Unit Parenteral Use

Dosage Strength : 1 vial groun EV 150 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

03

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Trastuzumab

Brand Name : Herceptin

Dosage Form : Trastuzumab 600Mg 1 Unit Parenteral Use

Dosage Strength : 1 vial SC 600 mg/5 ml 6 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

04

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Pertuzumab; Trastuzumab

Brand Name : Phesgo

Dosage Form : Injectable Solution

Dosage Strength : 1200mg;600mg

Packaging :

Approval Date : 21/12/2020

Application Number : 20200111000010

Regulatory Info : Approved

Registration Country : Sweden

blank

05

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Pertuzumabum; Trastuzumabum

Brand Name : Phesgo mg

Dosage Form : Solution For Injection

Dosage Strength : 600mg/10ml;600mg/10ml

Packaging :

Approval Date : 08/04/2021

Application Number : 67828

Regulatory Info : Allowed

Registration Country : Switzerland

blank

06

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Pertuzumabum; Trastuzumabum

Brand Name : Phesgo mg

Dosage Form : Solution For Injection

Dosage Strength : 1200mg/15ml;600mg/15ml

Packaging :

Approval Date : 08/04/2021

Application Number : 67828

Regulatory Info : Allowed

Registration Country : Switzerland

blank

07

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Pertuzumab; Trastuzumab

Brand Name : Phesgo

Dosage Form : Injectable Solution

Dosage Strength : 600mg/ml;600mg/ml

Packaging :

Approval Date : 21/12/2020

Application Number : 20200111000027

Regulatory Info : Approved

Registration Country : Sweden

blank

08

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Trastuzumab

Brand Name : Herceptin

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 150mg

Packaging :

Approval Date : 28/08/2000

Application Number : 20000828000019

Regulatory Info : Approved

Registration Country : Sweden

blank

09

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Trastuzumab

Brand Name : Herceptin

Dosage Form : Injectable Solution

Dosage Strength : 600mg/5ml

Packaging :

Approval Date : 26/08/2013

Application Number : 20120327000041

Regulatory Info : Approved

Registration Country : Sweden

blank

10

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Trastuzumab

Brand Name : Herewenda

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 150mg

Packaging :

Approval Date : 15/11/2023

Application Number : 20211222000011

Regulatory Info : Approved

Registration Country : Sweden

blank